{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:22:14Z","timestamp":1793114534732,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Major Project","award":["2017ZX09304030"],"award-info":[{"award-number":["2017ZX09304030"]}]},{"DOI":"10.13039\/501100010032","name":"Foundation of Shanghai Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["201640017"],"award-info":[{"award-number":["201640017"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Projects of Special Development Funds in Zhangjiang National Independent Innovation Demonstration Zone, Shanghai","award":["ZJ2017-ZD-012"],"award-info":[{"award-number":["ZJ2017-ZD-012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1941-0","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T12:01:02Z","timestamp":1559649662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing"],"prefix":"10.1186","volume":"17","author":[{"given":"Hui","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuguang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaorui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangman","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1767-5210","authenticated-orcid":false,"given":"Kai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"1941_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"1941_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"1941_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"1941_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"1941_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1073\/pnas.1422640112","volume":"112","author":"K Chen","year":"2015","unstructured":"Chen K, Yang D, Li X, Sun B, Song F, Cao W, Brat DJ, Gao Z, Li H, Liang H, et al. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proc Natl Acad Sci USA. 2015;112:1107\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1941_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23:703\u201313.","journal-title":"Nat Med"},{"key":"1941_CR7","first-page":"1540","volume":"7","author":"S Ge","year":"2017","unstructured":"Ge S, Li B, Li Y, Li Z, Liu Z, Chen Z, Wu J, Gao J, Shen L. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. Am J Cancer Res. 2017;7:1540\u201353.","journal-title":"Am J Cancer Res"},{"key":"1941_CR8","doi-asserted-by":"publisher","first-page":"e100442","DOI":"10.1371\/journal.pone.0100442","volume":"9","author":"Z Xu","year":"2014","unstructured":"Xu Z, Huo X, Ye H, Tang C, Nandakumar V, Lou F, Zhang D, Dong H, Sun H, Jiang S, et al. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform. PLoS ONE. 2014;9:e100442.","journal-title":"PLoS ONE"},{"key":"1941_CR9","doi-asserted-by":"crossref","first-page":"38389","DOI":"10.18632\/oncotarget.16409","volume":"8","author":"HS Kim","year":"2017","unstructured":"Kim HS, Lee H, Shin SJ, Beom SH, Jung M, Bae S, Lee EY, Park KH, Choi YY, Son T, et al. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer. Oncotarget. 2017;8:38389\u201398.","journal-title":"Oncotarget."},{"key":"1941_CR10","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.18632\/oncotarget.6921","volume":"7","author":"S Clave","year":"2016","unstructured":"Clave S, Gimeno J, Munoz-Marmol AM, Vidal J, Reguart N, Carcereny E, Pijuan L, Menendez S, Taus A, Mate JL, et al. ROS1 copy number alterations are frequent in non-small cell lung cancer. Oncotarget. 2016;7:8019\u201328.","journal-title":"Oncotarget"},{"key":"1941_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138.","journal-title":"Nature"},{"key":"1941_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"1941_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1385\/ENDO:12:3:237","volume":"12","author":"S Basu","year":"2000","unstructured":"Basu S, Dasgupta PS. Role of dopamine in malignant tumor growth. Endocrine. 2000;12:237\u201341.","journal-title":"Endocrine"},{"key":"1941_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.intimp.2016.07.002","volume":"39","author":"H Huang","year":"2016","unstructured":"Huang H, Wu K, Ma J, Du Y, Cao C, Nie Y. Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR\/AKT\/MMP-13 pathway. Int Immunopharmacol. 2016;39:113\u201320.","journal-title":"Int Immunopharmacol"},{"key":"1941_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3892\/ol.2017.5573","volume":"13","author":"J Mu","year":"2017","unstructured":"Mu J, Huang W, Tan Z, Li M, Zhang L, Ding Q, Wu X, Lu J, Liu Y, Dong Q, Xu H. Dopamine receptor D2 is correlated with gastric cancer prognosis. Oncol Lett. 2017;13:1223\u20137.","journal-title":"Oncol Lett"},{"key":"1941_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos E, Risueno RM, Laronde S, Shapovalova Z, Lee JH, Russell J, Malig M, McNicol JD, Fiebig-Comyn A, Graham M, et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell. 2012;149:1284\u201397.","journal-title":"Cell"},{"key":"1941_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrm778","volume":"3","author":"EI Christensen","year":"2002","unstructured":"Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002;3:256\u201366.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1941_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1055\/s-2006-925348","volume":"38","author":"TK Andreassen","year":"2006","unstructured":"Andreassen TK. The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids. Horm Metab Res. 2006;38:279\u201390.","journal-title":"Horm Metab Res"},{"key":"1941_CR19","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1158\/1078-0432.CCR-07-4566","volume":"14","author":"SK Holt","year":"2008","unstructured":"Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin Cancer Res. 2008;14:3823\u201331.","journal-title":"Clin Cancer Res"},{"key":"1941_CR20","doi-asserted-by":"publisher","first-page":"e66768","DOI":"10.1371\/journal.pone.0066768","volume":"8","author":"LN Anderson","year":"2013","unstructured":"Anderson LN, Cotterchio M, Knight JA, Borgida A, Gallinger S, Cleary SP. Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario. Canada. PLoS ONE. 2013;8:e66768.","journal-title":"Canada. PLoS ONE"},{"key":"1941_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4103\/1735-1995.168404","volume":"20","author":"S Khayatzadeh","year":"2015","unstructured":"Khayatzadeh S, Feizi A, Saneei P, Esmaillzadeh A. Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: A systematic review and meta-analysis. J Res Med Sci. 2015;20:790\u20136.","journal-title":"J Res Med Sci"},{"key":"1941_CR22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7555\/JBR.32.20170089","volume":"32","author":"SY Eom","year":"2018","unstructured":"Eom SY, Yim DH, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Kim YD, Kim H. Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 2018;32:257\u201363.","journal-title":"J Biomed Res"},{"key":"1941_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12876-018-0811-1","volume":"18","author":"D Wang","year":"2018","unstructured":"Wang D, Zhu H, Guo M, Fan X, Hu S, Yan K, Sun J, Wang J, Li M, Xiao H, Liu Z. Expression and prognostic value of cell-cycle-associated genes in gastric adenocarcinoma. BMC Gastroenterol. 2018;18:81.","journal-title":"BMC Gastroenterol"},{"key":"1941_CR24","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1158\/1078-0432.CCR-16-2217","volume":"23","author":"KK Hunt","year":"2017","unstructured":"Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, et al. Cytoplasmic cyclin E predicts recurrence in patients with breast cancer. Clin Cancer Res. 2017;23:2991\u20133002.","journal-title":"Clin Cancer Res"},{"key":"1941_CR25","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1158\/1078-0432.CCR-13-1337","volume":"19","author":"D Etemadmoghadam","year":"2013","unstructured":"Etemadmoghadam D, Au-Yeung G, Wall M, Mitchell C, Kansara M, Loehrer E, Batzios C, George J, Ftouni S, Weir BA, et al. Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer. Clin Cancer Res. 2013;19:5960\u201371.","journal-title":"Clin Cancer Res"},{"key":"1941_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/modpathol.2016.160","volume":"30","author":"A Ayhan","year":"2017","unstructured":"Ayhan A, Kuhn E, Wu RC, Ogawa H, Bahadirli-Talbott A, Mao TL, Sugimura H, Shih IM, Wang TL. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Mod Pathol. 2017;30:297\u2013303.","journal-title":"Mod Pathol"},{"key":"1941_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3892\/ijo.2013.2039","volume":"43","author":"G Liu","year":"2013","unstructured":"Liu G, Neumeister M, Reichensperger J, Yang RD. Therapeutic potential of human adipose stem cells in a cancer stem cell-like gastric cancer cell model. Int J Oncol. 2013;43:1301\u20139.","journal-title":"Int J Oncol"},{"key":"1941_CR28","first-page":"37","volume":"1795","author":"J Acquaviva","year":"2009","unstructured":"Acquaviva J, Wong R, Charest A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim Biophys Acta. 2009;1795:37\u201352.","journal-title":"Biochim Biophys Acta"},{"key":"1941_CR29","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","volume":"371","author":"AT Shaw","year":"2014","unstructured":"Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014;371:1963\u201371.","journal-title":"N Engl J Med"},{"key":"1941_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330\u20137.","journal-title":"Nature"},{"key":"1941_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"1941_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47:505\u201311.","journal-title":"Nat Genet"},{"key":"1941_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543\u201350.","journal-title":"Nature"},{"key":"1941_CR34","doi-asserted-by":"publisher","first-page":"12261","DOI":"10.3748\/wjg.v21.i43.12261","volume":"21","author":"SS Singh","year":"2015","unstructured":"Singh SS, Yap WN, Arfuso F, Kar S, Wang C, Cai W, Dharmarajan AM, Sethi G, Kumar AP. Targeting the PI3K\/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine? World J Gastroenterol. 2015;21:12261\u201373.","journal-title":"World J Gastroenterol"},{"key":"1941_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, Schrock A, Campbell B, Shlien A, Chmielecki J, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9:34.","journal-title":"Genome Med"},{"key":"1941_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.7098","author":"Z Wang","year":"2019","unstructured":"Wang Z, Duan J, Cai S, Han M, Dong H, Zhao J, Zhu B, Wang S, Zhuo M, Sun J, et al. Assessment of blood tumor mutational burden as a potential biomarker for immunotherapy in patients with non-small cell lung cancer with use of a next-generation sequencing cancer gene panel. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2018.7098 .","journal-title":"JAMA Oncol"},{"key":"1941_CR37","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"AM Goodman","year":"2017","unstructured":"Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther. 2017;16:2598\u2013608.","journal-title":"Mol Cancer Ther"},{"issue":"239\u2013254","key":"1941_CR38","first-page":"e236","volume":"23","author":"TA Knijnenburg","year":"2018","unstructured":"Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, et al. Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas. Cell Rep. 2018;23(239\u2013254):e236.","journal-title":"Cell Rep"},{"key":"1941_CR39","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1158\/1078-0432.CCR-16-2520","volume":"23","author":"MY Teo","year":"2017","unstructured":"Teo MY, Bambury RM, Zabor EC, Jordan E, Al-Ahmadie H, Boyd ME, Bouvier N, Mullane SA, Cha EK, Roper N, et al. DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma. Clin Cancer Res. 2017;23:3610\u20138.","journal-title":"Clin Cancer Res"},{"key":"1941_CR40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1200\/JCO.2017.75.7740","volume":"36","author":"MY Teo","year":"2018","unstructured":"Teo MY, Seier K, Ostrovnaya I, Regazzi AM, Kania BE, Moran MM, Cipolla CK, Bluth MJ, Chaim J, Al-Ahmadie H, et al. Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1\/PD-L1 blockade in advanced urothelial cancers. J Clin Oncol. 2018;36:1685\u201394.","journal-title":"J Clin Oncol"},{"key":"1941_CR41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007;28:622\u20139.","journal-title":"Hum Mutat"},{"key":"1941_CR42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1102","author":"M Offin","year":"2018","unstructured":"Offin M, Rizvi H, Tenet M, Ni A, Sanchez-Vega F, Li BT, Drilon A, Kris MG, Rudin CM, Schultz N, et al. Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers. Clin Cancer Res. 2018. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1102 .","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1941-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T01:37:31Z","timestamp":1694914651000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1941-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1941"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1941-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Changhai Hospital and Shandong Provincial Hospital. Informed consent was obtained from individuals for the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}